Proportion of liver cancer cases and deaths attributable to potentially modifiable risk factors in China

Abstract Background Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 3...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of epidemiology Vol. 52; no. 6; pp. 1805 - 1814
Main Authors Lin, Yushi, Zheng, Luyan, Fang, Kailu, Zheng, Yang, Wu, Jie, Zheng, Min
Format Journal Article
LanguageEnglish
Published England Oxford University Press 25.12.2023
Subjects
Online AccessGet full text
ISSN0300-5771
1464-3685
1464-3685
DOI10.1093/ije/dyad100

Cover

Loading…
Abstract Abstract Background Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016. Methods Prevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups. Results Approximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors. Conclusions The PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer.
AbstractList Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016. Prevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups. Approximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors. The PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer.
Abstract Background Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016. Methods Prevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups. Results Approximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors. Conclusions The PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer.
Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016.BACKGROUNDUnderstanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016.Prevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups.METHODSPrevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups.Approximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors.RESULTSApproximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors.The PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer.CONCLUSIONSThe PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer.
Author Lin, Yushi
Zheng, Luyan
Zheng, Yang
Wu, Jie
Fang, Kailu
Zheng, Min
Author_xml – sequence: 1
  givenname: Yushi
  surname: Lin
  fullname: Lin, Yushi
– sequence: 2
  givenname: Luyan
  surname: Zheng
  fullname: Zheng, Luyan
  email: minzheng@zju.edu.cn
– sequence: 3
  givenname: Kailu
  surname: Fang
  fullname: Fang, Kailu
– sequence: 4
  givenname: Yang
  surname: Zheng
  fullname: Zheng, Yang
  email: minzheng@zju.edu.cn
– sequence: 5
  givenname: Jie
  surname: Wu
  fullname: Wu, Jie
– sequence: 6
  givenname: Min
  orcidid: 0000-0001-6159-9879
  surname: Zheng
  fullname: Zheng, Min
  email: minzheng@zju.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37431632$$D View this record in MEDLINE/PubMed
BookMark eNp9kEtLAzEQgIMoWh8n75KTCLJ2ssk-epTiCwQ99L5kk1ka3SZrkhX67422ehD0MjMw3wwz3yHZtc4iIacMrhjM-NS84FSvpWYAO2TCRCkyXtbFLpkAB8iKqmIH5DCEFwAmhJjtkwNeCc5Knk_I8tm7wflonKWuo715R0-VtOorBQxUWk01yrhMZYzetGOUbY80Ojq4iDYa2fdrunLadOar4014pZ1U0flAjaXzpbHymOx1sg94ss1HZHF7s5jfZ49Pdw_z68dM8RxipotWsXR-XnClK6zrvK065KBRKAWaVTPGVJl-ystKQQp5atWqwBlwVSE_IhebtYN3byOG2KxMUNj30qIbQ5PXhRAcRAEJPduiY7tC3QzerKRfN99yEnC5AZR3IXjsfhAGzaf6JqlvtuoTzX7RykT5KTZ6afo_Zs43M24c_l3-Ac20lk0
CitedBy_id crossref_primary_10_14309_ajg_0000000000002778
crossref_primary_10_1002_ijc_35233
crossref_primary_10_12677_jcpm_2024_34324
crossref_primary_10_1007_s00262_024_03917_w
crossref_primary_10_1016_j_ejon_2024_102660
crossref_primary_10_3389_fpubh_2025_1523578
crossref_primary_10_2196_55657
crossref_primary_10_1007_s11912_024_01605_7
Cites_doi 10.1111/j.1360-0443.2011.03514.x
10.1186/1471-2458-12-967
10.1177/00368504211018081
10.1111/j.1349-7006.2009.01458.x
10.1210/jc.2008-1595
10.3322/caac.21440
10.1016/j.ijid.2011.10.009
10.1136/tobaccocontrol-2015-052534
10.1158/1940-6207.CAPR-13-0168
10.3109/23744235.2015.1064541
10.1186/s12879-019-4428-y
10.1016/j.jhep.2022.08.021
10.5993/AJHB.44.6.4
10.1001/jamaoncol.2018.5639
10.1016/j.vaccine.2009.08.048
10.1093/annonc/mdx342
10.1038/nrendo.2011.183
10.1016/j.diabres.2010.11.002
10.1001/jama.2013.168118
10.1038/s41574-019-0176-8
10.1016/S0140-6736(13)61097-1
10.1161/CIRCULATIONAHA.108.788166
10.1136/bmj.g7607
10.1371/journal.pone.0204221
10.1016/S2213-2600(18)30432-6
10.1093/ofid/ofz040
10.35772/ghm.2021.01037
10.1016/j.canep.2016.06.013
10.21147/j.issn.1000-9604.2017.03.11
10.21147/j.issn.1000-9604.2021.04.05
10.1002/ijc.21731
10.1016/S2214-109X(15)70017-3
10.1016/j.eclinm.2020.100521
10.1016/j.semcancer.2010.11.002
10.1371/journal.pntd.0005239
10.1093/annonc/mds139
10.1038/ajg.2013.160
10.3390/nu14051027
10.1016/S2214-109X(18)30488-1
10.1002/ijc.31088
10.1016/S2214-109X(21)00517-9
ContentType Journal Article
Copyright The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 2023
The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
Copyright_xml – notice: The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 2023
– notice: The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/ije/dyad100
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1464-3685
EndPage 1814
ExternalDocumentID 37431632
10_1093_ije_dyad100
10.1093/ije/dyad100
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 71904170
– fundername: Zhejiang University
– fundername: K. P. Chao's High Technology Development Foundation
  grantid: 2022RC017
– fundername: Zhejiang University K. P. Chao's High Technology Development Foundation
  grantid: 2022RC017
– fundername: Technological Innovation Leading Talents of "Ten Thousand Talents Plan" of Zhejiang Province
  grantid: 2020R52010
– fundername: Mega-Project of National Science and Technology for the 13th Five-Year Plan of China
  grantid: 2018ZX10721102-003-006
GroupedDBID ---
-E4
.2P
.GJ
.I3
.ZR
0R~
18M
1TH
29J
2WC
354
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
A8Z
AABZA
AACZT
AAJKP
AAJQQ
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAYJJ
ABDFA
ABEHJ
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNGD
ABNHQ
ABNKS
ABOCM
ABPQP
ABPTD
ABQLI
ABQTQ
ABSMQ
ABVGC
ABWST
ABXVV
ABYLZ
ABZBJ
ACFRR
ACGFO
ACGFS
ACIWK
ACPQN
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACVHY
ACZBC
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFCKW
AFFNX
AFFQV
AFFZL
AFIYH
AFOFC
AFRAH
AFSHK
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGQZG
AGSYK
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJDVS
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
AMHCJ
APIBT
APJGH
APWMN
AQDSO
AQKUS
ASPBG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
BWUDY
BZKNY
C1A
C45
CAG
CDBKE
CNZYI
COF
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EIHJH
EJD
EMOBN
F5P
F9B
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
FTKQU
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
MBLQV
N9A
NGC
NOMLY
NOYVH
NPJNY
NTWIH
NU-
NVLIB
O0~
O9-
OAWHX
OBFPC
OBS
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
SV3
TEORI
TJX
TMA
TR2
VH1
W2D
W8F
WH7
WOQ
X7H
YAYTL
YHZ
YKOAZ
YSK
YXANX
ZGI
ZKX
ZXP
~91
AAYXX
AGORE
AHGBF
AJBYB
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c320t-d5bc1368253cd7e882b7fe30de4cc0d17911c6577267c026720de8c5e903c7e3
ISSN 0300-5771
1464-3685
IngestDate Fri Jul 11 15:24:07 EDT 2025
Mon Jul 21 05:57:07 EDT 2025
Tue Jul 01 01:59:11 EDT 2025
Thu Apr 24 22:59:23 EDT 2025
Wed Apr 02 07:03:59 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Liver cancer
risk factor
China
prevention
population attributable fraction
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
https://academic.oup.com/pages/standard-publication-reuse-rights
The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c320t-d5bc1368253cd7e882b7fe30de4cc0d17911c6577267c026720de8c5e903c7e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6159-9879
PMID 37431632
PQID 2854430450
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_2854430450
pubmed_primary_37431632
crossref_primary_10_1093_ije_dyad100
crossref_citationtrail_10_1093_ije_dyad100
oup_primary_10_1093_ije_dyad100
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-12-25
PublicationDateYYYYMMDD 2023-12-25
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-25
  day: 25
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle International journal of epidemiology
PublicationTitleAlternate Int J Epidemiol
PublicationYear 2023
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Wang (2023122523574178700_dyad100-B49) 2020; 26
Gao (2023122523574178700_dyad100-B22) 2019; 6
Islami (2023122523574178700_dyad100-B28) 2018; 68
International Agency for Research on Cancer (IARC) (2023122523574178700_dyad100-B16) 2022
Hu (2023122523574178700_dyad100-B36) 2016; 25
Shi (2023122523574178700_dyad100-B47) 2011; 91
International Agency for Research on Cancer (2023122523574178700_dyad100-B2) 2020
Tsilidis (2023122523574178700_dyad100-B18) 2015; 350
Su (2023122523574178700_dyad100-B41) 2022; 10
Chen (2023122523574178700_dyad100-B25) 2012; 25
Tang (2023122523574178700_dyad100-B45) 2020; 44
National Statistical Office (2023122523574178700_dyad100-B29) 2011
Luo (2023122523574178700_dyad100-B39) 2012; 16
Lai (2023122523574178700_dyad100-B24) 2017; 11
Parkin (2023122523574178700_dyad100-B27) 2006; 118
Chen (2023122523574178700_dyad100-B7) 2013; 6
Wilson (2023122523574178700_dyad100-B31) 2018; 142
Shin (2023122523574178700_dyad100-B10) 2010; 101
Yu (2023122523574178700_dyad100-B1) 2021; 104
Misra (2023122523574178700_dyad100-B48) 2008; 93
Chen (2023122523574178700_dyad100-B5) 2011; 21
Li (2023122523574178700_dyad100-B35) 2011; 106
Wang (2023122523574178700_dyad100-B33) 2019; 7
Whiteman (2023122523574178700_dyad100-B11) 2016; 44
Wang (2023122523574178700_dyad100-B40) 2019; 19
Wu (2023122523574178700_dyad100-B26) 2008; 118
Wang (2023122523574178700_dyad100-B46) 2012; 12
Welzel (2023122523574178700_dyad100-B6) 2013; 108
Rumgay (2023122523574178700_dyad100-B9) 2022; 77
National Central Cancer (2023122523574178700_dyad100-B19) 2022
Islami (2023122523574178700_dyad100-B44) 2019; 5
Xu (2023122523574178700_dyad100-B14) 2018; 13
World Cancer Research Fund/American Institute for Cancer Research (2023122523574178700_dyad100-B17) 2018
WHO Regional Office for the Western Pacific (2023122523574178700_dyad100-B37) 2014
Islami (2023122523574178700_dyad100-B12) 2017; 28
Chen (2023122523574178700_dyad100-B21) 2011; 32
Wang (2023122523574178700_dyad100-B13) 2012; 23
Bluher (2023122523574178700_dyad100-B42) 2019; 15
Liang (2023122523574178700_dyad100-B20) 2009; 27
Xu (2023122523574178700_dyad100-B34) 2013; 310
Chen (2023122523574178700_dyad100-B30) 2019; 7
Inoue (2023122523574178700_dyad100-B32) 2022; 4
Chen (2023122523574178700_dyad100-B43) 2011; 8
Yang (2023122523574178700_dyad100-B3) 2013; 381
Chen (2023122523574178700_dyad100-B8) 2022; 14
Cai (2023122523574178700_dyad100-B4) 2017; 29
Zhang (2023122523574178700_dyad100-B23) 2015; 47
Cao (2023122523574178700_dyad100-B15) 2021; 33
Jiang (2023122523574178700_dyad100-B38) 2015; 3
References_xml – volume: 106
  start-page: 1946
  year: 2011
  ident: 2023122523574178700_dyad100-B35
  article-title: Drinking behaviour among men and women in China: the 2007 China chronic disease and risk factor surveillance
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2011.03514.x
– volume: 12
  start-page: 967
  year: 2012
  ident: 2023122523574178700_dyad100-B46
  article-title: Epidemiology of general obesity, abdominal obesity and related risk factors in urban adults from 33 communities of Northeast China: the CHPSNE study
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-12-967
– volume: 104
  start-page: 368504211018081
  year: 2021
  ident: 2023122523574178700_dyad100-B1
  article-title: Disease burden of liver cancer attributable to specific etiologies in China from 1990 to 2019: an age-period-cohort analysis
  publication-title: Sci Prog
  doi: 10.1177/00368504211018081
– volume: 101
  start-page: 579
  year: 2010
  ident: 2023122523574178700_dyad100-B10
  article-title: Epidemiology of cholangiocarcinoma: an update focusing on risk factors
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2009.01458.x
– year: 2022
  ident: 2023122523574178700_dyad100-B16
– volume: 93
  start-page: S9
  year: 2008
  ident: 2023122523574178700_dyad100-B48
  article-title: Obesity and the metabolic syndrome in developing countries
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-1595
– volume: 68
  start-page: 31
  year: 2018
  ident: 2023122523574178700_dyad100-B28
  article-title: Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21440
– volume: 16
  start-page: e82
  year: 2012
  ident: 2023122523574178700_dyad100-B39
  article-title: Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2011.10.009
– volume: 25
  start-page: 609
  year: 2016
  ident: 2023122523574178700_dyad100-B36
  article-title: China has raised the tax on cigarettes: what's next?
  publication-title: Tob Control
  doi: 10.1136/tobaccocontrol-2015-052534
– volume: 6
  start-page: 1038
  year: 2013
  ident: 2023122523574178700_dyad100-B7
  article-title: Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China
  publication-title: Cancer Prev Res (Phila)
  doi: 10.1158/1940-6207.CAPR-13-0168
– volume: 47
  start-page: 878
  year: 2015
  ident: 2023122523574178700_dyad100-B23
  article-title: A meta-analysis of HBsAg-positive rate among general Chinese populations aged 1–59 years
  publication-title: Infect Dis (Lond)
  doi: 10.3109/23744235.2015.1064541
– volume: 19
  start-page: 811
  year: 2019
  ident: 2023122523574178700_dyad100-B40
  article-title: Hepatitis B infection in the general population of China: a systematic review and meta-analysis
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-019-4428-y
– volume: 77
  start-page: 1598
  year: 2022
  ident: 2023122523574178700_dyad100-B9
  article-title: Global burden of primary liver cancer in 2020 and predictions to 2040
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2022.08.021
– volume: 44
  start-page: 780
  year: 2020
  ident: 2023122523574178700_dyad100-B45
  article-title: Differences in overweight and obesity between the north and south of China
  publication-title: Am J Health Behav
  doi: 10.5993/AJHB.44.6.4
– volume: 5
  start-page: 384
  year: 2019
  ident: 2023122523574178700_dyad100-B44
  article-title: Proportion of cancer cases attributable to excess body weight by US State, 2011-2015
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2018.5639
– year: 2022
  ident: 2023122523574178700_dyad100-B19
– year: 2020
  ident: 2023122523574178700_dyad100-B2
– volume: 27
  start-page: 6550
  year: 2009
  ident: 2023122523574178700_dyad100-B20
  article-title: Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.08.048
– year: 2011
  ident: 2023122523574178700_dyad100-B29
– volume: 28
  start-page: 2567
  year: 2017
  ident: 2023122523574178700_dyad100-B12
  article-title: Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdx342
– volume: 8
  start-page: 228
  year: 2011
  ident: 2023122523574178700_dyad100-B43
  article-title: The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2011.183
– volume: 25
  start-page: 163
  year: 2012
  ident: 2023122523574178700_dyad100-B25
  article-title: Analysis of the results of two nationwide surveys on Clonorchis sinensis infection in China
  publication-title: Biomed Environ Sci
– volume: 91
  start-page: 389
  year: 2011
  ident: 2023122523574178700_dyad100-B47
  article-title: Prevalence of obesity and associated risk factors in Northeastern China
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2010.11.002
– volume: 310
  start-page: 948
  year: 2013
  ident: 2023122523574178700_dyad100-B34
  article-title: Prevalence and control of diabetes in Chinese adults
  publication-title: JAMA
  doi: 10.1001/jama.2013.168118
– volume: 15
  start-page: 288
  year: 2019
  ident: 2023122523574178700_dyad100-B42
  article-title: Obesity: global epidemiology and pathogenesis
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/s41574-019-0176-8
– volume: 381
  start-page: 1987
  year: 2013
  ident: 2023122523574178700_dyad100-B3
  article-title: Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)61097-1
– volume: 118
  start-page: 2679
  year: 2008
  ident: 2023122523574178700_dyad100-B26
  article-title: Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.788166
– volume: 350
  start-page: g7607
  year: 2015
  ident: 2023122523574178700_dyad100-B18
  article-title: Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
  publication-title: BMJ
  doi: 10.1136/bmj.g7607
– volume: 13
  start-page: e0204221
  year: 2018
  ident: 2023122523574178700_dyad100-B14
  article-title: Cancer mortality attributable to cigarette smoking in 2005, 2010 and 2015 in Qingdao, China
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0204221
– volume: 7
  start-page: 35
  year: 2019
  ident: 2023122523574178700_dyad100-B33
  article-title: Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(18)30432-6
– volume: 6
  start-page: ofz040
  year: 2019
  ident: 2023122523574178700_dyad100-B22
  article-title: Prevalence of anti-HCV antibody among the general population in mainland China between 1991 and 2015: a systematic review and meta-analysis
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofz040
– volume: 4
  start-page: 26
  year: 2022
  ident: 2023122523574178700_dyad100-B32
  article-title: Burden of cancer attributable to modifiable factors in Japan in 2015
  publication-title: Glob Health Med
  doi: 10.35772/ghm.2021.01037
– volume: 44
  start-page: 203
  year: 2016
  ident: 2023122523574178700_dyad100-B11
  article-title: The fractions of cancer attributable to modifiable factors: a global review
  publication-title: Cancer Epidemiol
  doi: 10.1016/j.canep.2016.06.013
– year: 2014
  ident: 2023122523574178700_dyad100-B37
– year: 2018
  ident: 2023122523574178700_dyad100-B17
– volume: 29
  start-page: 253
  year: 2017
  ident: 2023122523574178700_dyad100-B4
  article-title: Expenditure of hospital care on cancer in China, from 2011 to 2015
  publication-title: Chin J Cancer Res
  doi: 10.21147/j.issn.1000-9604.2017.03.11
– volume: 33
  start-page: 480
  year: 2021
  ident: 2023122523574178700_dyad100-B15
  article-title: Attributable deaths of liver cancer in China
  publication-title: Chin J Cancer Res
  doi: 10.21147/j.issn.1000-9604.2021.04.05
– volume: 118
  start-page: 3030
  year: 2006
  ident: 2023122523574178700_dyad100-B27
  article-title: The global health burden of infection-associated cancers in the year 2002
  publication-title: Int J Cancer
  doi: 10.1002/ijc.21731
– volume: 3
  start-page: e190
  year: 2015
  ident: 2023122523574178700_dyad100-B38
  article-title: Alcohol and related health issues in China: action needed
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(15)70017-3
– volume: 26
  start-page: 100521
  year: 2020
  ident: 2023122523574178700_dyad100-B49
  article-title: Prevalence and changes of BMI categories in China and related chronic diseases: Cross-sectional National Health Service Surveys (NHSSs) from 2013 to 2018
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2020.100521
– volume: 21
  start-page: 59
  year: 2011
  ident: 2023122523574178700_dyad100-B5
  article-title: Liver cancer epidemic in China: past, present and future
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2010.11.002
– volume: 11
  start-page: e0005239
  year: 2017
  ident: 2023122523574178700_dyad100-B24
  article-title: Risk mapping of clonorchiasis in the People's Republic of China: a systematic review and Bayesian geostatistical analysis
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0005239
– volume: 23
  start-page: 2983
  year: 2012
  ident: 2023122523574178700_dyad100-B13
  article-title: Attributable causes of cancer in China
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mds139
– volume: 32
  start-page: 888
  year: 2011
  ident: 2023122523574178700_dyad100-B21
  article-title: A sero-epidemiological study on hepatitis C in China
  publication-title: Zhonghua Liu Xing Bing Xue Za Zhi
– volume: 108
  start-page: 1314
  year: 2013
  ident: 2023122523574178700_dyad100-B6
  article-title: Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2013.160
– volume: 14
  start-page: 1027
  year: 2022
  ident: 2023122523574178700_dyad100-B8
  article-title: Burden of disease associated with dietary exposure to aflatoxins in China in 2020
  publication-title: Nutrients
  doi: 10.3390/nu14051027
– volume: 7
  start-page: e257
  year: 2019
  ident: 2023122523574178700_dyad100-B30
  article-title: Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(18)30488-1
– volume: 142
  start-page: 691
  year: 2018
  ident: 2023122523574178700_dyad100-B31
  article-title: How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31088
– volume: 10
  start-page: e278
  year: 2022
  ident: 2023122523574178700_dyad100-B41
  article-title: Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(21)00517-9
SSID ssj0014449
Score 2.4850874
Snippet Abstract Background Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and...
Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer...
SourceID proquest
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1805
SubjectTerms Alcohol Drinking - adverse effects
Alcohol Drinking - epidemiology
China - epidemiology
Female
Hepatitis C - epidemiology
Humans
Liver Neoplasms - epidemiology
Liver Neoplasms - etiology
Male
Risk Factors
Smoking - adverse effects
Smoking - epidemiology
Weight Gain
Title Proportion of liver cancer cases and deaths attributable to potentially modifiable risk factors in China
URI https://www.ncbi.nlm.nih.gov/pubmed/37431632
https://www.proquest.com/docview/2854430450
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZtCiEQQpu-0vShQk4FJ7Yl27vHEJqGNik9bGFzMrIkExfXXrL2YfPrOyPJj2XT0vYiG0trgb9vxzPjeRByBCYyy2OtvBy0AY9zoT0hAukFIs7hbchlqNE1cPU1vvjOP8-j-eiLKWaXNNmxvLs3r-R_UIVrgCtmyf4Dsv1N4QKcA74wAsIw_hXG37DFwW2n85UYYoFRXNIcltqWX1ao5MFpY3tbmVQpUDgXdYOBQqIsV9gOp8gLM2NCzbsmPJgR2PXX7jTYdRfiqPCEHnrN9m76S1uh4Lpd3hSDi1pb-XLZrgZqnju_9RdRlO3G0mvhXrDOPxEyjPWwuczH2spUHnMP69yPhW4Ujsg1lqDBxKRhb4p2W_aq-KFhVCuhAlPhtBnBvPhpcGaoFMXOa7peS7ubekgehWBWoCD_NO9DgsC25FOXwwm7ncBeJ26nHbLd_XZNgVlLitywTYyOMntM9pxxQU8tU56QB7raJ9tXLnxin-xaJy21uWdPyc1AIFrn1BCIWgJRQyAKBKKWQHRMINrUdEQgOhCIIoGoIxAtKmoI9IzMzj_Ozi4813rDkyz0G09FmQwAszBiUiUazLAsyTXzleZS-gpr2gYyjuAZxonEJmYhTE1kpKc-k4lmz8lWVVf6JaGcKTaNfMlZznmSsKlKooRlLMgUGPuT5IB86B5nKl1ZeuyOUqY2PIKlAEPqYDggR_3iha3Gcv-yd4DLn1e87zBLQZ7iRzJR6bpdpphRzDF8ANa8sGD2N-oo8Oq3M4dkZ_gPvCZbzW2r34DW2mRvDdV-AbklnDA
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Proportion+of+liver+cancer+cases+and+deaths+attributable+to+potentially+modifiable+risk+factors+in+China&rft.jtitle=International+journal+of+epidemiology&rft.au=Lin%2C+Yushi&rft.au=Zheng%2C+Luyan&rft.au=Fang%2C+Kailu&rft.au=Zheng%2C+Yang&rft.date=2023-12-25&rft.eissn=1464-3685&rft.volume=52&rft.issue=6&rft.spage=1805&rft_id=info:doi/10.1093%2Fije%2Fdyad100&rft_id=info%3Apmid%2F37431632&rft.externalDocID=37431632
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-5771&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-5771&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-5771&client=summon